Have a question?
Just email us.
Meet the ‘who’ behind the ‘what’ we do.
At Beta Bionics, we’re a people-focused company here to serve the wider diabetes community. As you’d expect, we’ve got incredible technical expertise and skills on our team to enable us to do that. But just as important, our people are a great bunch of human beings too. All committed and passionate in helping our community live fuller, more enjoyable lives.
Our leadership team
Our board of directors
Board observers
Katie Hewitt
VP, and Chief Business Officer, Lilly New Ventures at Eli Lilly and Company
Finny Kuruvilla, MD, PhD
Co-Chief Investment Officer, Senior Portfolio Manager, Managing Director, Founding Member at Eventide Asset Management
Marie Lindegaard, MD, DMSc
Corporate Project Vice President for Diabetes, Clinical Drug Development, Novo Nordisk
Ken Lutchen
Dean of Engineering, Boston University
Michael Pratt
Managing Director, Technology Development at Boston University
Harish Chandra Soundararajan, PhD
Investment Director, Farallon Capital
David Kendall, MD
Chief Medical Officer, Zealand Pharma
